Empowering States to Address Drug Costs Act
Official title: A bill to amend title XIX of the Social Security Act to expand the permitted uses of drug price information disclosed to States under the Medicaid drug rebate program.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Empowering States to Address Drug Costs Act
This bill expands the purposes for which states may use certain drug pricing information that is disclosed to them by manufacturers through the Medicaid Drug Rebate Program. Specifically, the bill allows states to use such information in furtherance of prescription drug affordability boards or state multi-payer purchasing pools.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2252: Empowering States to Address Drug Costs Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-2252/
"S. 2252: Empowering States to Address Drug Costs Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2252/.
S. 2252, 116th Cong. (2026), https://openamerica.io/bill/116-S-2252/.
[S. 2252: Empowering States to Address Drug Costs Act](https://openamerica.io/bill/116-S-2252/)